Southpoint Master Fund, LP 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-08 08:46 am Unchanged |
2024-04-08 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 5,276,699 4.900% |
0 (Unchanged) |
Filing |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 5,276,699 5.200% |
776,699 (+17.26%) |
Filing |
| 2022-07-11 4:01 pm Purchase |
2022-06-30 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 4,500,000 5.100% |
1,500,000 (+50.00%) |
Filing |
| 2022-02-10 4:31 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 3,000,000 3.400% |
3,000,000 (New Position) |
Filing |